Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Influenza

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    November 2022
  1. ROY T, Sharma K, Dhall A, Patiyal S, et al
    In silico method for predicting infectious strains of influenza A virus from its genome and protein sequences.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


  2. GRAND RJ
    A link between severe hepatitis in children and adenovirus 41 and adeno-associated virus 2 infections.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


  3. DEMPSEY R, Ritter L, Parker L
    Strain development of A/H1N1pdm09 candidate vaccine viruses for the 2021-22 northern hemisphere influenza season.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    July 2022
  4. SHARTOUNY JR, Lowen AC
    Message in a bottle: mRNA vaccination for influenza.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    June 2022
  5. LIU L, Weiss A, Saul VV, Schermuly RT, et al
    Comparative kinase activity profiling of pathogenic influenza A viruses reveals new anti- and pro-viral protein kinases.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    May 2022
  6. DE MOOR WRJ, Regnard GL, Rybicki EP, Williamson AL, et al
    Characterization of a dynamic self-replicating mammalian expression vector based on the circular ssDNA genome of beak and feather disease virus.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    April 2022
  7. THAKUR N, Gallo G, Newman J, Peacock TP, et al
    SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    March 2022
  8. DOLINSKI AC, Homola JJ, Jankowski MD, Robinson JD, et al
    Differential gene expression reveals host factors for viral shedding variation in mallards (Anas platyrhynchos) infected with low-pathogenic avian influenza virus.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    November 2021
  9. SEALY JE, Howard WA, Molesti E, Iqbal M, et al
    Amino acid substitutions in the H5N1 avian influenza haemagglutinin alter pH of fusion and receptor binding to promote a highly pathogenic phenotype in chickens.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  10. ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
    MicroRNAs affect GPCR and Ion channel genes needed for influenza replication.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  11. VIANA K, Zarpelon L, Leandro A, Terencio M, et al
    Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  12. SZYMCZAK A, Jedruchniewicz N, Torelli A, Kaczmarzyk-Radka A, et al
    Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    October 2021
  13. HUSSAIN S, Daniels RS, Wharton SA, Howell S, et al
    Reduced sialidase activity of influenza A(H3N2) neuraminidase associated with positively charged amino acid substitutions.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  14. MHAMDI Z, Carbonneau J, Venable MC, Baz M, et al
    Replication and transmission of an influenza A(H3N2) virus harboring the polymerase acidic I38T substitution, in guinea pigs.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  15. OLBRICH L, Castelletti N, Schalte Y, Gari M, et al
    Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    September 2021
  16. STALLER E, Sheppard CM, Baillon L, Frise R, et al
    A natural variant in ANP32B impairs influenza virus replication in human cells.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    August 2021
  17. HIRST JC, Hutchinson EC
    Corrigendum: Single-particle measurements of filamentous influenza virions reveal damage induced by freezing.
    J Gen Virol. 2021;102.
    PubMed    


  18. RAHMAN F, Libre C, Oleinikov A, Tcherniuk S, et al
    Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    July 2021
  19. POHL MO, Busnadiego I, Marrafino F, Wiedmer L, et al
    Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    June 2021
  20. ELGENDY EM, Arai Y, Kawashita N, Isobe A, et al
    Double mutations in the H9N2 avian influenza virus PB2 gene act cooperatively to increase viral host adaptation and replication for human infections.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  21. CHAPPELL JG, Tsoleridis T, Clark G, Berry L, et al
    Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    May 2021
  22. DISSANAYAKE TK, Yan B, Ng AC, Zhao H, et al
    Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  23. GOLDEN JW, Zeng X, Cline CR, Garrison AR, et al
    Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  24. ZHANG QY, Deng CL, Liu J, Li JQ, et al
    SARS-CoV-2 replicon for high-throughput antiviral screening.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    April 2021
  25. HENSS L, Auste A, Schurmann C, Schmidt C, et al
    The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  26. SMITHER SJ, Eastaugh LS, Findlay JS, Laws TR, et al
    Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  27. PEACOCK TP, Penrice-Randal R, Hiscox JA, Barclay WS, et al
    SARS-CoV-2 one year on: evidence for ongoing viral adaptation.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  28. DAVIES K, Buczkowski H, Welch SR, Green N, et al
    Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    March 2021
  29. MONCHATRE-LEROY E, Lesellier S, Wasniewski M, Picard-Meyer E, et al
    Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  30. GUPTA A, Sabarinathan R, Bala P, Donipadi V, et al
    A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  31. ROE MK, Junod NA, Young AR, Beachboard DC, et al
    Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  32. AUERSWALD H, Yann S, Dul S, In S, et al
    Assessment of inactivation procedures for SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  33. SIMMONDS P, Williams S, Harvala H
    Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    February 2021
  34. KHALIL AM, Yoshida R, Masatani T, Takada A, et al
    Variation in the HA antigenicity of A(H1N1)pdm09-related swine influenza viruses.
    J Gen Virol. 2021 Feb 22. doi: 10.1099/jgv.0.001569.
    PubMed     Abstract available


  35. CLEMENTS AL, Peacock TP, Sealy JE, Lee HM, et al
    PA-X is an avian virulence factor in H9N2 avian influenza virus.
    J Gen Virol. 2021 Feb 5. doi: 10.1099/jgv.0.001531.
    PubMed     Abstract available


    January 2021
  36. KIM DI, Cho YB, Lim Y, Hong SH, et al
    Chios mastic gum inhibits influenza A virus replication and viral pathogenicity.
    J Gen Virol. 2021 Jan 8. doi: 10.1099/jgv.0.001550.
    PubMed     Abstract available


  37. THAKUR N, Conceicao C, Isaacs A, Human S, et al
    Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    December 2020
  38. HARRIS M
    Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020.
    J Gen Virol. 2020;101:1227-1228.
    PubMed    


    November 2020
  39. YU J, Li F, Wang D
    The first decade of research advances in influenza D virus.
    J Gen Virol. 2020 Nov 19. doi: 10.1099/jgv.0.001529.
    PubMed     Abstract available


  40. KLIMSTRA WB, Tilston-Lunel NL, Nambulli S, Boslett J, et al
    SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
    J Gen Virol. 2020;101:1156-1169.
    PubMed     Abstract available


    October 2020
  41. LI Y, Chai W, Min J, Ye Z, et al
    Neddylation of M1 negatively regulates the replication of influenza A virus.
    J Gen Virol. 2020 Oct 5. doi: 10.1099/jgv.0.001503.
    PubMed     Abstract available


  42. FIRTH AE
    A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
    J Gen Virol. 2020;101:1085-1089.
    PubMed     Abstract available


  43. SILVA SJRD, Germano Mendes RP, Alves da Silva CT, Lorusso A, et al
    Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems.
    J Gen Virol. 2020;101:1021-1024.
    PubMed     Abstract available


  44. RENNICK LJ, Nambulli S, Lemon K, Olinger GY, et al
    Recombinant subtype A and B human respiratory syncytial virus clinical isolates co-infect the respiratory tract of cotton rats.
    J Gen Virol. 2020;101:1056-1068.
    PubMed     Abstract available


  45. RIJSBERGEN LC, Rennick LJ, Laksono BM, van Run PRWA, et al
    In vivo comparison of a laboratory-adapted and clinical-isolate-based recombinant human respiratory syncytial virus.
    J Gen Virol. 2020;101:1037-1046.
    PubMed     Abstract available


    September 2020
  46. MOOIJ P, Mortier D, Stammes M, Fagrouch Z, et al
    Aerosolized pH1N1 influenza infection induces less systemic and local immune activation in the lung than combined intrabronchial, nasal and oral exposure in cynomolgus macaques.
    J Gen Virol. 2020 Sep 25. doi: 10.1099/jgv.0.001489.
    PubMed     Abstract available


  47. WANG J, Xu X, Zhou X, Chen P, et al
    Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection.
    J Gen Virol. 2020;101:921-924.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: